XML 23 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income $ 1,425 $ 1,117 $ 1,721
Income (loss) from discontinued operations, net of tax 12 35 185
Income from continuing operations 1,413 1,082 1,536
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation, decommissioning and amortization 2,098 2,005 1,815
Allowance for equity during construction (74) (87) (65)
Impairment and other charges 0 5 157
Deferred income taxes and investment tax credits 190 449 522
Other 20 (28) 20
Nuclear decommissioning trusts (179) (428) 39
EME settlement payments, net of insurance proceeds (209) (176) (225)
Changes in operating assets and liabilities:      
Receivables 52 49 64
Inventory 8 14 (25)
Accounts payable 35 8 14
Prepaid and accrued taxes (6) (28) (100)
Other current assets and liabilities 211 (24) (103)
Derivative assets and liabilities, net 13 45 (40)
Regulatory assets and liabilities, net (292) 1,729 (358)
Other noncurrent assets and liabilities (24) (106) (3)
Net cash provided by operating activities 3,256 4,509 3,248
Cash flows from financing activities:      
Long-term debt issued or remarketed, net of discount and issuance costs 397 1,420 494
Long-term debt matured or repurchased (220) (762) (607)
Preference stock issued, net 294 319 269
Preference stock redeemed (125) (325) 0
Short-term debt financing, net 611 (572) 1,079
Dividends to noncontrolling interests (123) (116) (111)
Dividends paid (626) (544) (463)
Other (113) (8) (16)
Net cash (used in) provided by financing activities 95 (588) 645
Cash flows from investing activities:      
Capital expenditures (3,734) (4,225) (3,906)
Proceeds from sale of nuclear decommissioning trust investments 3,212 3,506 2,617
Purchases of nuclear decommissioning trust investments (3,033) (3,132) (2,661)
Life insurance policy loans proceeds 140 0 0
Other (1) (41) 43
Net cash used in investing activities (3,416) (3,892) (3,907)
Net (decrease) increase in cash and cash equivalents (65) 29 (14)
Cash and cash equivalents, beginning of year 161 132 146
Cash and cash equivalents, end of year 96 161 132
Southern California Edison Company      
Cash flows from operating activities:      
Net income 1,499 1,111 1,565
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation, decommissioning and amortization 2,085 1,996 1,810
Allowance for equity during construction (74) (87) (65)
Impairment and other charges 0 0 163
Deferred income taxes and investment tax credits 88 308 462
Other 9 14 11
Nuclear decommissioning trusts (179) (428) 39
Changes in operating assets and liabilities:      
Receivables 25 25 64
Inventory (3) 19 (19)
Accounts payable 45 30 12
Prepaid and accrued taxes (16) (16) 129
Other current assets and liabilities 185 (42) (107)
Derivative assets and liabilities, net 13 45 (40)
Regulatory assets and liabilities, net (292) 1,729 (358)
Other noncurrent assets and liabilities 138 (80) (6)
Net cash provided by operating activities 3,523 4,624 3,660
Cash flows from financing activities:      
Long-term debt issued or remarketed, net of discount and issuance costs 0 1,413 498
Long-term debt matured or repurchased (217) (761) (607)
Preference stock issued, net 294 319 269
Preference stock redeemed (125) (325) 0
Short-term debt financing, net 719 (619) 490
Dividends paid (824) (874) (489)
Other (66) 35 20
Net cash (used in) provided by financing activities (219) (812) 181
Cash flows from investing activities:      
Capital expenditures (3,633) (4,210) (3,857)
Proceeds from sale of nuclear decommissioning trust investments 3,212 3,506 2,617
Purchases of nuclear decommissioning trust investments (3,033) (3,132) (2,661)
Life insurance policy loans proceeds 140 0 0
Other 23 12 44
Net cash used in investing activities (3,291) (3,824) (3,857)
Net (decrease) increase in cash and cash equivalents 13 (12) (16)
Cash and cash equivalents, beginning of year 26 38 54
Cash and cash equivalents, end of year $ 39 $ 26 $ 38